Structural variation is widespread in mammalian genomes 1, 2 and is an important cause of disease 3 , but just how abundant and important structural variants (SVs) are in shaping phenotypic variation remains unclear 4, 5 . Without knowing how many SVs there are, and how they arise, it is difficult to discover what they do. Combining experimental with automated analyses, we identified 711,920 SVs at 281,243 sites in the genomes of thirteen classical and four wildderived inbred mouse strains. The majority of SVs are less than 1 kilobase in size and 98% are deletions or insertions. The breakpoints of 160,000 SVs were mapped to base pair resolution, allowing us to infer that insertion of retrotransposons causes more than half of SVs. Yet, despite their prevalence, SVs are less likely than other sequence variants to cause gene expression or quantitative phenotypic variation. We identified 24 SVs that disrupt coding exons, acting as rare variants of large effect on gene function. One-third of the genes so affected have immunological functions.
Structural variation is widespread in mammalian genomes 1,2 and is an important cause of disease 3 , but just how abundant and important structural variants (SVs) are in shaping phenotypic variation remains unclear 4, 5 . Without knowing how many SVs there are, and how they arise, it is difficult to discover what they do. Combining experimental with automated analyses, we identified 711,920 SVs at 281,243 sites in the genomes of thirteen classical and four wildderived inbred mouse strains. The majority of SVs are less than 1 kilobase in size and 98% are deletions or insertions. The breakpoints of 160,000 SVs were mapped to base pair resolution, allowing us to infer that insertion of retrotransposons causes more than half of SVs. Yet, despite their prevalence, SVs are less likely than other sequence variants to cause gene expression or quantitative phenotypic variation. We identified 24 SVs that disrupt coding exons, acting as rare variants of large effect on gene function. One-third of the genes so affected have immunological functions.
The pre-eminent organism for modelling the relationship between phenotype and genotype, including SVs, is the mouse, but our catalogue of SVs in this animal is incomplete 6 and most of what we know about the impact of SVs on phenotypes comes from analyses of gene expression 7, 8 . Up to 28% of the between-strain variation in gene expression in haematopoietic stem and progenitor cells has been attributed to SVs 7 ; SVs may account for between 66% and 74% of between-strain expression variation in kidney, liver, lung and testis 8 . Because gene expression variation is believed to contribute to variation in phenotypes in the whole organism 9 , SVs may turn out to have a major role in the genetic determination of many aspects of mouse biology.
Combining short-read paired-end mapping with experimental analyses (Supplementary Methods), we found SVs greater than 100 base pairs (bp) at 281,243 sites in the mouse genome, amounting to 711,920 SVs in thirteen classical and four wild-derived inbred strains of mice (Supplementary Table 1a ), affecting 1.2% (33.0 Mb) and 3.7% (98.2 Mb) of the genome respectively (Supplementary Table 1b) . Deletions, a category we can measure accurately, have a median size of 349 bp with modes at 100 bp and 6,400 bp ( Supplementary Fig. 1a ).
Our catalogue contains far more SVs than previously identified: 99.4% of SVs are simple and 0.6% are complex (Supplementary  Table 1a) , where simple SVs include insertions, deletions, inversions and copy number gains, and complex SVs consist of a mixture of events that abut each other. From experimental analyses of simple deletion SVs, we estimated an average false-negative rate of 17% in the classical inbred strains (Supplementary Tables 2a, b and 3a) and 24% in the wild-derived strains (Supplementary Table 2b) ; falsepositive rates were below 5% for all strains (Supplementary Table  2c ). False-negative rates for non-deletion simple SVs as well as complex SVs were higher than for simple deletions, ranging from 24% to 31% and 35% to 54% per strain, respectively (Supplementary Table 3b ).
It proved difficult to obtain robust estimates of SVs smaller than 100 bp. Our best estimate of the rate of SVs between 30 and 100 bp is based on combining manual and automated methods over a region of 7.2 Mb (Supplementary Methods). Assuming that this region is typical, the rest of the genome (in classical laboratory strains) should contain approximately 49,000 SVs in this size range.
Microhomology at SV breakpoints, as well as the sequence content within SVs and the SV's ancestral state, were used to infer the likely mechanism of formation for simple SVs. To obtain breakpoint sequence, we performed de novo local assembly for 80.3% of deletions. Comparison of 1,314 predicted deletion breakpoints to the breakpoint delineated by PCR and sequencing (Supplementary Table 5a ). In cases where the local assembly strategy failed, we relied on the original breakpoint estimates obtained from the mapping of reads to the reference genome: 83.3% of these estimates are within 100 bp of the actual breakpoint (Supplementary  Table 5b ). Breakpoint accuracy for insertions, inversions and copy number gains is presented in Supplementary Table 5c, d and e, respectively.
Genome-wide estimates of the contribution of each mechanism to SV formation were derived from analysis of breakpoint sequence of deletions relative to C57BL/6J. We have highly accurate breakpoint sequence for this SV category, which should be unbiased with respect to ancestry. Using rat as an outgroup, we classified 19% of relative deletion SVs as ancestral deletions, 57% as ancestral insertions and the remainder (24%) were indeterminate ( Supplementary Fig. 2 ).
SVs are most often due to retrotransposons (long interspersed nuclear elements (LINEs; 25%), long terminal repeats (LTRs; 14%) and short interspersed nuclear elements (SINEs; 15%)), followed by variable number tandem repeats (VNTRs) (15%) and pseudogenes (2%). Other mechanisms, not involving retrotransposons, account for 29% of SVs. Outgroup analysis showed that the transposon-associated SVs arose almost exclusively from ancestral insertions events (98.8%). Target site duplications (12-16 bp) surround the breakpoints of LINE and SINE derived SVs; shorter (6-8 bp) sequences are associated with LTR SVs (Supplementary Fig. 1b ). Non-repeat-mediated SVs are mainly a result of ancestral deletion events (79%), and are associated with microhomologies up to 7 bp in length ( Supplementary Fig. 1b) , consistent with either microhomology-mediated break-induced replication 10 or microhomology-mediated end joining 11 . Given their potential role in human disease 12 , we were interested to document the occurrence of SVs that arise at the same genomic locus independently in unrelated strains (recurrent SVs). Non-allelic homologous recombination (NAHR) is the major mechanism for recurrent SVs 13 , whereas fork stalling and template switching and/or microhomology-mediated break-induced replication mechanisms may be important for non-recurrent SVs 14 .
Using the SV breakpoints obtained from PCR sequencing (249 SV sites in eight strains, accounting for over 4,000 breakpoints, Supplementary Table 4 ), we identified SVs occurring at the same locus in different strains, but with different breakpoints, indicating independent origins. In the classical strains, only 2.5% of deletions at the same locus had different breakpoint sequences. However within all 17 strains we found multiple alleles at 12% of SVs, due almost entirely to the presence of different alleles originating from the wild-derived inbred strains. Consistent with the low frequency of recurrent SVs, breakpoint features associated with NAHR are rare. We estimated that 0.13% of deletions are due to NAHR, when we required a signature of $200 bp of $90% sequence identity.
We assessed the impact of SVs on phenotypes by first estimating the proportion of heritability attributable to SVs 8 from brain RNA-seq and found that no category accounts for more than 10% (Fig. 1) . To determine if these results were specific to brain tissue, we analysed gene expression data for the eight founder strains of the heterogeneous stock (HS) population (n 5 5 for each) from liver, measured on Illumina gene-expression arrays 15 . Mean heritability attributable to an SV, for transcripts overlapping one or more SVs, was 9.5%. Because many transcripts overlap multiple small SVs (median of 3, maximum of 216), we proposed that SV heritability might be related to the amount of gene overlapped. For each transcript we summed the amount of DNA overlapping a gene and expressed this as a proportion of the total length of the gene. SVs that overlap 50% or more of a gene make a large contribution to heritability: in brain tissue, such SVs contribute to 25% of the variance, compared to 7.8% for transcripts where SVs overlap less than 50% of the gene. However, large overlaps (50% or more) are rare, affecting less than 3% of transcripts. Thus, whereas SVs make a modest contribution to the overall heritability of expression variance, at individual transcripts they may be the main cause of between-strain differences in expression.
As another method to assess the impact of SVs on phenotype, we applied a test of functionality 16 to 281,246 SVs in association with 100 phenotypes measured in over 2,000 HS mice 17 . We identified 290 quantitative trait loci (QTLs) where SVs were among the variants most likely to be functional, but in all these cases the SVs were only a subset of the total number of functional variants. We found a small but highly significant deficit in SVs among the functional variants (0.36% compared to 0.54% among the non-functional, P , 10 216 , x 2 5 72.1). Whereas SVs make a relatively small contribution to the total amount of quantitative phenotypic variation, at a small number of QTLs they are the cause of variation. As shown in an accompanying paper 18 , larger effect QTLs are more likely to arise from SVs. We identified 12 QTLs where the SV overlapped a gene or flanking region (2 kb up and downstream), and where the QTL effect size is in the top 5% of the distribution. Table 1 lists these SVs, the genes they affect and the putative phenotype with which they are associated. Two associations have been directly tested: complementation of the deletion of the H2-Ea promoter has confirmed the effect of this SV on the T-cell phenotype 19 ; analysis of a knock out of Eps15 showed the predicted lower locomotor activity (Fig. 2a) .
There are relatively few examples where an SV can be said unequivocally to delete one, or more, coding exons. Without nucleotide resolution accuracy we cannot be certain whether the breakpoint of an SV lies within an exon. Therefore to find SVs overlapping exons we used our most accurate and complete category of SV calls: deletions relative to C57BL/6J. We identified 210 that overlap exons (Ensembl Build 58); after removing pseudogenes, and genes not annotated as 'protein coding', we were left with 24 SVs that affect coding exons, including six that encompass a gene in its entirety ( Table 2) .
Five of the 24 SVs are already known [20] [21] [22] [23] [24] ; the remaining 19 are novel. A third of the genes affected are involved in immunity and infection. Our data expand current knowledge of the molecular architecture of these SVs. Figure 2b shows that antiviral genes Trim5 and Trim12a are unique to C57BL/6J, due to segmental duplication 25 . All the other strains contain only the Trim12c gene. Therefore the mouse contains a unique homologue of the human TRIM5 gene. A similar analysis revealed that documented exonic changes in the defensin beta 8 gene (Defb8) 26 are linked to a previously undetected 3,192-bp ancestral insertion plus a 54-bp deletion (Table 2) .
Our results are important in three respects. First, we find an unexpectedly large number of SVs with diverse molecular architecture, thus providing a catalogue of the most dynamic and variable regions of the mouse genome. Second, we were able to map almost 60% of deletions to base-pair resolution, allowing us to classify SVs by the mechanism that created them. In contrast to human SV studies, the great majority of SVs that we have discovered are non-recurrent rearrangements, based on two observations: among the classical strains, only 2.5% of deletions at the same locus had different breakpoint sequences and less than 1% of deletions are due to NAHR 12 . Third, SVs have relatively little impact on gene function, a conclusion based on the following observations. We found that SVs overlapping a gene account for less than 10% of variation in gene 
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expression, three to four times less than that found by studies using expression arrays 7, 8 . SVs overlapping exons are rare: because the frequency of insertions is equal to that of deletions, and because these two categories make up 98% of all SVs, extrapolating from the 24 SVs that delete exons, we predict that there are only about 50 SVs that directly overlap exons, or about 0.2% of the total burden of SVs in the genome. Finally, our analysis of the phenotypic consequences of SVs on QTLs for multiple phenotypes points to a relative deficit of SVs as the molecular basis of complex phenotypes. For the classical laboratory strains, single nucleotide polymorphisms (SNPs) and indels affect 0.5% of the genome, whereas on average 33 Mb (1.2%) of each classical laboratory strain falls into structurally variant regions of the genome. This implies that SVs are at least twice as likely to have phenotypic consequences than the combined effect of SNPs and indels. Yet we find that SVs contribute only 10% to the heritability of gene expression, not the 50% implied by the genomic size argument.
It is important to note that conclusions based on our analysis of the HS outbred population may not apply to other outbred populations. The mouse population we tested is derived from inbred progenitors whose homozygosity will have purged their genomes of variants that could otherwise be maintained in heterozygous freely mating populations. Nevertheless, despite their relative rarity in the mouse genome, SVs that cause phenotype change are likely to provide biological insights out of proportion to their relative small contribution to phenotypic variance. We expect that the alleles we have described will provide a starting point for investigating the relationship between phenotype and genotype in mice.
METHODS SUMMARY
SV discovery. We used a combination of four computational methods: split-read mapping 27 , mate-pair analysis 28 , single-end cluster analysis (SECluster and RetroSeq), and read-depth 29 . These methods identify deletions, insertions, inversions and copy number gains. We also derived methods to recognize other types of rearrangements, such as inversion plus insertion or inversion plus deletion, newly revealed from our experimental analysis. Experimental analysis. We visually inspected short-read sequencing data using LookSeq 30 and manually detected SVs across mouse chromosome 19 in its entirety and a random set of other chromosomal regions. We analysed molecular structures of these SVs at nucleotide-level resolution using PCR and Sanger-based sequencing. Outgroup analysis. The rat was used as an outgroup species to classify each mouse SV as either an ancestral deletion or an ancestral insertion. We predicted the ancestral state in the rat by estimating the size of the region in the rat genome that was homologous to the region that encompassed the mouse SV. SV classification. We developed a machine learning method to classify SVs. The method used a random forest classifier, trained using sequence features within the SVs. Microhomology between breakpoints was determined by recording the longest sequence of bases that was identical between each breakpoint of each SV. Functional impact of SVs. We tested whether an SV is likely to be functional using merge analysis 16 . The variances of expression data were calculated using ANOVA in the statistical software R using formulae described in ref. 8 and also by comparing a model where the expression value is explained by the strain, to a model in which the expression is explained by strain and whether or not the animal has an SV. 
